For profit Phase 1
Founded: Plymouth MN United States (2000)
Status: Acquired by Covidien (2010)

Organization Overview

First Clinical Trial
2005
NCT00720577
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Mergers & Acquisitions

Historical Acquisition Tree